A Study Comparing LY900014 to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes Using Insulin Pump Therapy (PRONTO-Pump-2)
I8B-MC-ITRO - ClinicalTrials.gov - NCT03830281
The reason for this study is to compare the study drug LY900014 to insulin lispro when both are used in insulin pump therapy in adults with type 1 diabetes (T1D).
Trial Summary
Age Range
≥18 yearsConditions the trial is for
Type 1 DiabetesWhat the trial is testing?
Insulin Lispro, Ultra-Rapid LisproCould I receive a Placebo?
NoEnrollment Goal
471Trial Dates
Feb 14, 2019 - Jan 6, 2020How long will I be in the trial?
The study will last about 23 weeks and may include up to 12 clinic visits and 2 telephone appointments.Trial Phase
IIILilly Trial Alerts
Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.
You will complete the questionnaire on another website.YesNo